Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03525795
Title ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals


lung non-small cell carcinoma

renal cell carcinoma

transitional cell carcinoma

Advanced Solid Tumor


CPI-1205 + Ipilimumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.